Canada embarking on a process to modernize its cost recovery regime for health products.

Health Canada is embarking on a process to modernize its cost recovery regime for health products.

The Budget Implementation Act, 2017 amended the Food and Drugs Act to provide Health Canada with new authorities to establish an agile cost recovery system capable of supporting regulatory system delivery and transformation, while maintaining transparency and accountability principles.

Applicable fee regulations under the Financial Administration Act have been repealed and new fee regulations are established under the Food and Drugs Act. Health Canada has used these new authorities to update and revise existing fees for human drugs, veterinary drugs and medical devices to better reflect costs of program delivery.

Products covered : Drug Products – Prescription and Non-prescription; Medical devices products; Veterinary drugs

HS code: 30, 9018, 9026

Proposed date of adoption: 29 May 2019

Proposed date of entry into force: 1 April 2020

Final date for comments: Not applicable

If the Proposal/Notification/Regulation will affect your International Business please send us your representation with facts and figures , so that these can be taken up suitably.